Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero.

Hedlund M, Thorlacius GE, Ivanchenko M, Ottosson V, Kyriakidis N, Lagnefeldt L, Tingström J, Sirsjö A, Bengtsson AA, Aronsson E, Gemzell-Danielsson K, Ronnblom L, Bergman G, Espinosa A, Sonesson SE, Eloranta ML, Wahren-Herlenius M.

RMD Open. 2020 Jan;6(1). pii: e000989. doi: 10.1136/rmdopen-2019-000989.

2.

Sex differences in clinical presentation of systemic lupus erythematosus.

Ramírez Sepúlveda JI, Bolin K, Mofors J, Leonard D, Svenungsson E, Jönsen A, Bengtsson C; DISSECT consortium, Nordmark G, Rantapää Dahlqvist S, Bengtsson AA, Rönnblom L, Sjöwall C, Gunnarsson I, Wahren-Herlenius M.

Biol Sex Differ. 2019 Dec 16;10(1):60. doi: 10.1186/s13293-019-0274-2.

3.

Neutrophil extracellular traps identify patients at risk of increased disease activity and cardiovascular comorbidity in systemic lupus erythematosus.

Moore S, Juo HH, Nielsen CT, Tyden H, Bengtsson AA, Lood C.

J Rheumatol. 2019 Dec 15. pii: jrheum.190875. doi: 10.3899/jrheum.190875. [Epub ahead of print]

PMID:
31839592
4.

Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome.

Wirestam L, Arve S, Linge P, Bengtsson AA.

Front Immunol. 2019 Nov 22;10:2734. doi: 10.3389/fimmu.2019.02734. eCollection 2019. Review.

5.

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.

Sohrabian A, Parodis I, Carlströmer-Berthén N, Frodlund M, Jönsen A, Zickert A, Sjöwall C, Bengtsson AA, Gunnarsson I, Rönnelid J.

Arthritis Res Ther. 2019 Nov 29;21(1):259. doi: 10.1186/s13075-019-2056-y.

6.

Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population.

Ingvarsson RF, Landgren AJ, Bengtsson AA, Jönsen A.

Lupus. 2019 Oct;28(12):1488-1494. doi: 10.1177/0961203319877947. Epub 2019 Sep 24.

PMID:
31551031
7.

Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus.

Tydén H, Lood C, Jönsen A, Gullstrand B, Kahn R, Linge P, Kumaraswamy SB, Dahlbäck B, Bengtsson AA.

Arthritis Res Ther. 2019 May 2;21(1):110. doi: 10.1186/s13075-019-1890-2.

8.

Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus.

Almlöf JC, Nystedt S, Leonard D, Eloranta ML, Grosso G, Sjöwall C, Bengtsson AA, Jönsen A, Gunnarsson I, Svenungsson E, Rönnblom L, Sandling JK, Syvänen AC.

Hum Genet. 2019 Feb;138(2):141-150. doi: 10.1007/s00439-018-01966-7. Epub 2019 Feb 1.

9.

A rare regulatory variant in the MEF2D gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts.

Farias FHG, Dahlqvist J, Kozyrev SV, Leonard D, Wilbe M, Abramov SN, Alexsson A, Pielberg GR, Hansson-Hamlin H, Andersson G, Tandre K, Bengtsson AA, Sjöwall C, Svenungsson E, Gunnarsson I, Rantapää-Dahlqvist S, Syvänen AC, Sandling JK, Eloranta ML, Rönnblom L, Lindblad-Toh K.

Eur J Hum Genet. 2019 Mar;27(3):432-441. doi: 10.1038/s41431-018-0297-x. Epub 2018 Nov 20.

10.

Active NET formation in Libman-Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus.

Appelgren D, Dahle C, Knopf J, Bilyy R, Vovk V, Sundgren PC, Bengtsson AA, Wetterö J, Muñoz LE, Herrmann M, Höög A, Sjöwall C.

Autoimmunity. 2018 Sep;51(6):310-318. doi: 10.1080/08916934.2018.1514496. Epub 2018 Oct 28.

11.

Smoking reduces the efficacy of belimumab in mucocutaneous lupus.

Parodis I, Gomez A, Frodlund M, Jönsen A, Zickert A, Sjöwall C, Bengtsson AA, Gunnarsson I.

Expert Opin Biol Ther. 2018 Aug;18(8):911-920. doi: 10.1080/14712598.2018.1494719. Epub 2018 Jul 9.

12.

The non-haemostatic role of platelets in systemic lupus erythematosus.

Linge P, Fortin PR, Lood C, Bengtsson AA, Boilard E.

Nat Rev Rheumatol. 2018 Mar 21;14(4):195-213. doi: 10.1038/nrrheum.2018.38. Review.

PMID:
29559714
13.

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.

Leonard D, Svenungsson E, Dahlqvist J, Alexsson A, Ärlestig L, Taylor KE, Sandling JK, Bengtsson C, Frodlund M, Jönsen A, Eketjäll S, Jensen-Urstad K, Gunnarsson I, Sjöwall C, Bengtsson AA, Eloranta ML, Syvänen AC, Rantapää-Dahlqvist S, Criswell LA, Rönnblom L.

Ann Rheum Dis. 2018 Jul;77(7):1063-1069. doi: 10.1136/annrheumdis-2017-212614. Epub 2018 Mar 7.

14.

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus.

Imgenberg-Kreuz J, Carlsson Almlöf J, Leonard D, Alexsson A, Nordmark G, Eloranta ML, Rantapää-Dahlqvist S, Bengtsson AA, Jönsen A, Padyukov L, Gunnarsson I, Svenungsson E, Sjöwall C, Rönnblom L, Syvänen AC, Sandling JK.

Ann Rheum Dis. 2018 May;77(5):736-743. doi: 10.1136/annrheumdis-2017-212379. Epub 2018 Feb 1.

15.

Stress-induced release of the S100A8/A9 alarmin is elevated in coronary artery disease patients with impaired cortisol response.

Jonasson L, Grauen Larsen H, Lundberg AK, Gullstrand B, Bengtsson AA, Schiopu A.

Sci Rep. 2017 Dec 13;7(1):17545. doi: 10.1038/s41598-017-17586-6.

16.

Role of interferons in SLE.

Bengtsson AA, Rönnblom L.

Best Pract Res Clin Rheumatol. 2017 Jun;31(3):415-428. doi: 10.1016/j.berh.2017.10.003. Epub 2017 Nov 3. Review.

PMID:
29224681
17.

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus.

Martin M, Smoląg KI, Björk A, Gullstrand B, Okrój M, Leffler J, Jönsen A, Bengtsson AA, Blom AM.

Arthritis Res Ther. 2017 Dec 6;19(1):266. doi: 10.1186/s13075-017-1470-2.

18.

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus.

Tydén H, Lood C, Gullstrand B, Nielsen CT, Heegaard NHH, Kahn R, Jönsen A, Bengtsson AA.

RMD Open. 2017 Oct 25;3(2):e000508. doi: 10.1136/rmdopen-2017-000508. eCollection 2017.

19.

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.

Ramírez Sepúlveda JI, Kvarnström M, Eriksson P, Mandl T, Norheim KB, Johnsen SJ, Hammenfors D, Jonsson MV, Skarstein K, Brun JG; DISSECT consortium, Rönnblom L, Forsblad-d'Elia H, Magnusson Bucher S, Baecklund E, Theander E, Omdal R, Jonsson R, Nordmark G, Wahren-Herlenius M.

Biol Sex Differ. 2017 Aug 8;8(1):25. doi: 10.1186/s13293-017-0146-6.

20.

Novel risk genes for systemic lupus erythematosus predicted by random forest classification.

Almlöf JC, Alexsson A, Imgenberg-Kreuz J, Sylwan L, Bäcklin C, Leonard D, Nordmark G, Tandre K, Eloranta ML, Padyukov L, Bengtsson C, Jönsen A, Dahlqvist SR, Sjöwall C, Bengtsson AA, Gunnarsson I, Svenungsson E, Rönnblom L, Sandling JK, Syvänen AC.

Sci Rep. 2017 Jul 24;7(1):6236. doi: 10.1038/s41598-017-06516-1.

21.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

22.

A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus.

Olsson LM, Johansson ÅC, Gullstrand B, Jönsen A, Saevarsdottir S, Rönnblom L, Leonard D, Wetterö J, Sjöwall C, Svenungsson E, Gunnarsson I, Bengtsson AA, Holmdahl R.

Ann Rheum Dis. 2017 Sep;76(9):1607-1613. doi: 10.1136/annrheumdis-2017-211287. Epub 2017 Jun 12.

PMID:
28606963
23.

Comment on: Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus: reply.

Lood C, Bengtsson AA.

Rheumatology (Oxford). 2017 Aug 1;56(8):1437-1438. doi: 10.1093/rheumatology/kex216. No abstract available.

PMID:
28605487
24.

Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis.

Berthold E, Månsson B, Gullstrand B, Geborek P, Saxne T, Bengtsson AA, Kahn R.

Scand J Rheumatol. 2018 Jan;47(1):22-26. doi: 10.1080/03009742.2017.1290822. Epub 2017 May 9.

PMID:
28485187
25.

Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.

Nagel J, Saxne T, Geborek P, Bengtsson AA, Jacobsen S, Svaerke Joergensen C, Nilsson JÅ, Skattum L, Jönsen A, Kapetanovic MC.

Lupus. 2017 Sep;26(10):1072-1081. doi: 10.1177/0961203317695465. Epub 2017 Feb 26.

PMID:
28420056
26.

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus.

Parodis I, Sjöwall C, Jönsen A, Ramsköld D, Zickert A, Frodlund M, Sohrabian A, Arnaud L, Rönnelid J, Malmström V, Bengtsson AA, Gunnarsson I.

Autoimmun Rev. 2017 Apr;16(4):343-351. doi: 10.1016/j.autrev.2017.02.005. Epub 2017 Feb 13. Review.

PMID:
28216072
27.

Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.

Lood C, Tydén H, Gullstrand B, Nielsen CT, Heegaard NH, Linge P, Jönsen A, Hesselstrand R, Kahn R, Bengtsson AA.

Rheumatology (Oxford). 2017 Mar 1;56(3):408-416. doi: 10.1093/rheumatology/kew437.

PMID:
28031442
28.

Blood-borne phagocytes internalize urate microaggregates and prevent intravascular NETosis by urate crystals.

Pieterse E, Jeremic I, Czegley C, Weidner D, Biermann MH, Veissi S, Maueröder C, Schauer C, Bilyy R, Dumych T, Hoffmann M, Munoz LE, Bengtsson AA, Schett G, van der Vlag J, Herrmann M.

Sci Rep. 2016 Dec 5;6:38229. doi: 10.1038/srep38229.

29.

Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity.

Delfani P, Sturfelt G, Gullstrand B, Carlsson A, Kassandra M, Borrebaeck CA, Bengtsson AA, Wingren C.

Lupus. 2017 Apr;26(4):373-387. doi: 10.1177/0961203316669240. Epub 2016 Sep 30.

PMID:
27694630
30.

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis.

Bengtsson AA, Trygg J, Wuttge DM, Sturfelt G, Theander E, Donten M, Moritz T, Sennbro CJ, Torell F, Lood C, Surowiec I, Rännar S, Lundstedt T.

PLoS One. 2016 Jul 21;11(7):e0159384. doi: 10.1371/journal.pone.0159384. eCollection 2016.

31.

Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.

Tydén H, Lood C, Gullstrand B, Jönsen A, Ivars F, Leanderson T, Bengtsson AA.

Lupus. 2017 Feb;26(2):139-149. doi: 10.1177/0961203316655208. Epub 2016 Jul 19.

PMID:
27407135
32.

Systemic lupus erythematosus: still a challenge for physicians.

Bengtsson AA, Rönnblom L.

J Intern Med. 2017 Jan;281(1):52-64. doi: 10.1111/joim.12529. Epub 2016 Jun 16. Review.

33.

Differences in body structure and function between patients with systemic lupus erythematosus and healthy individuals, with particular reference to joint hypermobility.

Johnsson PM, Kohlin C, Rasmusson GR, Bengtsson AA, Sturfelt G, Nived O.

Scand J Rheumatol. 2017 Jan;46(1):40-43. doi: 10.3109/03009742.2016.1158313. Epub 2016 May 12.

PMID:
27172144
34.

Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus.

Lood C, Tydén H, Gullstrand B, Jönsen A, Källberg E, Mörgelin M, Kahn R, Gunnarsson I, Leanderson T, Ivars F, Svenungsson E, Bengtsson AA.

Arthritis Rheumatol. 2016 Aug;68(8):1970-80. doi: 10.1002/art.39656.

35.

Variations in the epidemiology of systemic lupus erythematosus in southern Sweden.

Ingvarsson RF, Bengtsson AA, Jönsen A.

Lupus. 2016 Jun;25(7):772-80. doi: 10.1177/0961203316635288. Epub 2016 Feb 27.

PMID:
26923282
36.

The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study.

Compagno M, Gullstrand B, Jacobsen S, Eilertsen GØ, Nilsson JÅ, Lood C, Jönsen A, Truedsson L, Sturfelt G, Bengtsson AA.

Arthritis Res Ther. 2016 Feb 10;18:44. doi: 10.1186/s13075-016-0941-1.

37.

Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.

Jönsen A, Hjalte F, Willim M, Carlsson KS, Sjöwall C, Svenungsson E, Leonard D, Bengtsson C, Rantapää-Dahlqvist S, Pettersson S, Gunnarsson I, Zickert A, Gustafsson JT, Rönnblom L, Petersson IF, Bengtsson AA, Nived O.

Semin Arthritis Rheum. 2016 Jun;45(6):684-90. doi: 10.1016/j.semarthrit.2015.11.013. Epub 2015 Dec 2.

PMID:
26743074
38.

Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.

Kahn R, Berthold E, Gullstrand B, Schmidt T, Kahn F, Geborek P, Saxne T, Bengtsson AA, Månsson B.

Acta Paediatr. 2016 Apr;105(4):427-32. doi: 10.1111/apa.13319. Epub 2016 Feb 1.

39.

The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.

Kozarcanin H, Lood C, Munthe-Fog L, Sandholm K, Hamad OA, Bengtsson AA, Skjoedt MO, Huber-Lang M, Garred P, Ekdahl KN, Nilsson B.

J Thromb Haemost. 2016 Mar;14(3):531-45. doi: 10.1111/jth.13208. Epub 2016 Feb 15.

40.

A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources.

Leffler J, Ciacma K, Gullstrand B, Bengtsson AA, Martin M, Blom AM.

Arthritis Res Ther. 2015 Aug 13;17:205. doi: 10.1186/s13075-015-0726-y.

41.

A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa.

Mohanty T, Sjögren J, Kahn F, Abu-Humaidan AH, Fisker N, Assing K, Mörgelin M, Bengtsson AA, Borregaard N, Sørensen OE.

Blood. 2015 Oct 29;126(18):2128-37. doi: 10.1182/blood-2015-04-641142. Epub 2015 Aug 4.

PMID:
26243777
42.

Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort.

Jönsen A, Bengtsson AA, Hjalte F, Petersson IF, Willim M, Nived O.

Lupus. 2015 Oct;24(12):1248-56. doi: 10.1177/0961203315584812. Epub 2015 May 8.

PMID:
25957301
43.

Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.

Lood C, Tydén H, Gullstrand B, Klint C, Wenglén C, Nielsen CT, Heegaard NH, Jönsen A, Kahn R, Bengtsson AA.

PLoS One. 2015 Apr 21;10(4):e0125109. doi: 10.1371/journal.pone.0125109. eCollection 2015.

44.

Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.

Johansson ÅC, Ohlsson S, Pettersson Å, Bengtsson AA, Selga D, Hansson M, Hellmark T.

Arthritis Res Ther. 2016 Apr 22;18:92. doi: 10.1186/s13075-016-0994-1.

45.

Hand function and performance of daily activities in systemic lupus erythematosus: a clinical study.

Malcus Johnsson P, Sandqvist G, Nilsson JÅ, Bengtsson AA, Sturfelt G, Nived O.

Lupus. 2015 Jul;24(8):827-34. doi: 10.1177/0961203314565690. Epub 2014 Dec 26.

PMID:
25542902
46.

Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden.

Mohammad AJ, Weiner M, Sjöwall C, Johansson ME, Bengtsson AA, Ståhl-Hallengren C, Nived O, Eriksson P, Sturfelt G, Segelmark M.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i23-30. doi: 10.1093/ndt/gfu396. Epub 2014 Dec 23.

PMID:
25540097
47.

Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study.

Compagno M, Rekvig OP, Bengtsson AA, Sturfelt G, Heegaard NH, Jönsen A, Jacobsen RS, Eilertsen GØ, Fenton CG, Truedsson L, Nossent JC, Jacobsen S.

Lupus Sci Med. 2014 Apr 1;1(1):e000007. doi: 10.1136/lupus-2013-000007. eCollection 2014.

48.

Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.

Lood C, Tydén H, Gullstrand B, Sturfelt G, Jönsen A, Truedsson L, Bengtsson AA.

PLoS One. 2014 Jun 12;9(6):e99386. doi: 10.1371/journal.pone.0099386. eCollection 2014.

49.

Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus.

Bengtsson AA, Pettersson Å, Wichert S, Gullstrand B, Hansson M, Hellmark T, Johansson ÅC.

Arthritis Res Ther. 2014 Jun 5;16(3):R120. doi: 10.1186/ar4575.

50.

The complement system in systemic lupus erythematosus: an update.

Leffler J, Bengtsson AA, Blom AM.

Ann Rheum Dis. 2014 Sep;73(9):1601-6. doi: 10.1136/annrheumdis-2014-205287. Epub 2014 May 20. Review.

PMID:
24845390

Supplemental Content

Loading ...
Support Center